<?xml version="1.0" encoding="utf-8"?>
<Return xmlns="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.irs.gov/efile" returnVersion="2022v5.0">
  <ReturnHeader binaryAttachmentCnt="0">
    <ReturnTs>2023-11-10T16:09:19-06:00</ReturnTs>
    <TaxPeriodEndDt>2022-12-31</TaxPeriodEndDt>
    <PreparerFirmGrp>
      <PreparerFirmEIN>320530003</PreparerFirmEIN>
      <PreparerFirmName>
        <BusinessNameLine1Txt>QUIGLEY &amp; MIRON</BusinessNameLine1Txt>
      </PreparerFirmName>
      <PreparerUSAddress>
        <AddressLine1Txt>3550 WILSHIRE BLVD 1660</AddressLine1Txt>
        <CityNm>LOS ANGELES</CityNm>
        <StateAbbreviationCd>CA</StateAbbreviationCd>
        <ZIPCd>90010</ZIPCd>
      </PreparerUSAddress>
    </PreparerFirmGrp>
    <ReturnTypeCd>990</ReturnTypeCd>
    <TaxPeriodBeginDt>2022-01-01</TaxPeriodBeginDt>
    <Filer>
      <EIN>263006100</EIN>
      <BusinessName>
        <BusinessNameLine1Txt>PABLOVE FOUNDATION INC</BusinessNameLine1Txt>
      </BusinessName>
      <BusinessNameControlTxt>PABL</BusinessNameControlTxt>
      <PhoneNum>3236575557</PhoneNum>
      <USAddress>
        <AddressLine1Txt>3255 CAHUENGA BLVD WEST 210</AddressLine1Txt>
        <CityNm>LOS ANGELES</CityNm>
        <StateAbbreviationCd>CA</StateAbbreviationCd>
        <ZIPCd>90068</ZIPCd>
      </USAddress>
    </Filer>
    <BusinessOfficerGrp>
      <PersonNm>TINA SCHWARTZ</PersonNm>
      <PersonTitleTxt>BOARD CHAIR</PersonTitleTxt>
      <PhoneNum>3236575557</PhoneNum>
      <SignatureDt>2023-11-10</SignatureDt>
    </BusinessOfficerGrp>
    <SigningOfficerGrp>
      <PersonFullName>
        <PersonFirstNm>TINA</PersonFirstNm>
        <PersonLastNm>SCHWARTZ</PersonLastNm>
      </PersonFullName>
      <SSN>999009999</SSN>
    </SigningOfficerGrp>
    <IRSResponsiblePrtyInfoCurrInd>0</IRSResponsiblePrtyInfoCurrInd>
    <PreparerPersonGrp>
      <PreparerPersonNm>ARMEN GRIGORIAN</PreparerPersonNm>
      <PTIN>P01582463</PTIN>
      <PhoneNum>2136393550</PhoneNum>
    </PreparerPersonGrp>
    <AdditionalFilerInformation>
      <TrustedCustomerGrp>
        <TrustedCustomerCd>2</TrustedCustomerCd>
        <AuthenticationAssuranceLevelCd>AAL1</AuthenticationAssuranceLevelCd>
        <IdentityAssuranceLevelCd>IAL1</IdentityAssuranceLevelCd>
      </TrustedCustomerGrp>
    </AdditionalFilerInformation>
    <TaxYr>2022</TaxYr>
    <BuildTS>2023-04-26 12:10:37Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCnt="9">
    <IRS990 documentId="RetDoc1038000001" referenceDocumentId="RetDoc1044400001">
      <PrincipalOfficerNm>TINA SCHWARTZ</PrincipalOfficerNm>
      <USAddress>
        <AddressLine1Txt>3255 CAHUENGA BLVD WEST 210</AddressLine1Txt>
        <CityNm>LOS ANGELES</CityNm>
        <StateAbbreviationCd>CA</StateAbbreviationCd>
        <ZIPCd>90068</ZIPCd>
      </USAddress>
      <GrossReceiptsAmt>1625652</GrossReceiptsAmt>
      <GroupReturnForAffiliatesInd>0</GroupReturnForAffiliatesInd>
      <Organization501c3Ind>X</Organization501c3Ind>
      <WebsiteAddressTxt>PABLOVE.ORG</WebsiteAddressTxt>
      <TypeOfOrganizationCorpInd>X</TypeOfOrganizationCorpInd>
      <FormationYr>2008</FormationYr>
      <LegalDomicileStateCd>CA</LegalDomicileStateCd>
      <ActivityOrMissionDesc>INVEST IN CUTTING EDGE PEDIATRIC CANCER RESEARCH; IMPROVE LIVES FOR CHILDREN LIVING WITH CANCER THROUGH PHOTOGRAPHY.</ActivityOrMissionDesc>
      <VotingMembersGoverningBodyCnt>13</VotingMembersGoverningBodyCnt>
      <VotingMembersIndependentCnt>12</VotingMembersIndependentCnt>
      <TotalEmployeeCnt>16</TotalEmployeeCnt>
      <TotalVolunteersCnt>41</TotalVolunteersCnt>
      <TotalGrossUBIAmt>0</TotalGrossUBIAmt>
      <NetUnrelatedBusTxblIncmAmt>0</NetUnrelatedBusTxblIncmAmt>
      <PYContributionsGrantsAmt>1565271</PYContributionsGrantsAmt>
      <CYContributionsGrantsAmt>706201</CYContributionsGrantsAmt>
      <PYProgramServiceRevenueAmt>0</PYProgramServiceRevenueAmt>
      <CYProgramServiceRevenueAmt>0</CYProgramServiceRevenueAmt>
      <PYInvestmentIncomeAmt>42307</PYInvestmentIncomeAmt>
      <CYInvestmentIncomeAmt>34741</CYInvestmentIncomeAmt>
      <PYOtherRevenueAmt>9427</PYOtherRevenueAmt>
      <CYOtherRevenueAmt>3294</CYOtherRevenueAmt>
      <PYTotalRevenueAmt>1617005</PYTotalRevenueAmt>
      <CYTotalRevenueAmt>744236</CYTotalRevenueAmt>
      <PYGrantsAndSimilarPaidAmt>227500</PYGrantsAndSimilarPaidAmt>
      <CYGrantsAndSimilarPaidAmt>112500</CYGrantsAndSimilarPaidAmt>
      <PYBenefitsPaidToMembersAmt>0</PYBenefitsPaidToMembersAmt>
      <CYBenefitsPaidToMembersAmt>0</CYBenefitsPaidToMembersAmt>
      <PYSalariesCompEmpBnftPaidAmt>972060</PYSalariesCompEmpBnftPaidAmt>
      <CYSalariesCompEmpBnftPaidAmt>843898</CYSalariesCompEmpBnftPaidAmt>
      <PYTotalProfFndrsngExpnsAmt>0</PYTotalProfFndrsngExpnsAmt>
      <CYTotalProfFndrsngExpnsAmt>0</CYTotalProfFndrsngExpnsAmt>
      <CYTotalFundraisingExpenseAmt>268586</CYTotalFundraisingExpenseAmt>
      <PYOtherExpensesAmt>642488</PYOtherExpensesAmt>
      <CYOtherExpensesAmt>559568</CYOtherExpensesAmt>
      <PYTotalExpensesAmt>1842048</PYTotalExpensesAmt>
      <CYTotalExpensesAmt>1515966</CYTotalExpensesAmt>
      <PYRevenuesLessExpensesAmt>-225043</PYRevenuesLessExpensesAmt>
      <CYRevenuesLessExpensesAmt>-771730</CYRevenuesLessExpensesAmt>
      <TotalAssetsBOYAmt>2838766</TotalAssetsBOYAmt>
      <TotalAssetsEOYAmt>1877983</TotalAssetsEOYAmt>
      <TotalLiabilitiesBOYAmt>78027</TotalLiabilitiesBOYAmt>
      <TotalLiabilitiesEOYAmt>144923</TotalLiabilitiesEOYAmt>
      <NetAssetsOrFundBalancesBOYAmt>2760739</NetAssetsOrFundBalancesBOYAmt>
      <NetAssetsOrFundBalancesEOYAmt>1733060</NetAssetsOrFundBalancesEOYAmt>
      <InfoInScheduleOPartIIIInd>X</InfoInScheduleOPartIIIInd>
      <MissionDesc>THE MISSION OF THE PABLOVE FOUNDATION IS TO INVEST IN UNDERFUNDED, CUTTING-EDGE PEDIATRIC CANCER RESEARCH, AND TO IMPROVE THE LIVES OF CHILDREN LIVING WITH CANCER THROUGH THE ARTS.</MissionDesc>
      <SignificantNewProgramSrvcInd>0</SignificantNewProgramSrvcInd>
      <SignificantChangeInd>0</SignificantChangeInd>
      <ExpenseAmt>567893</ExpenseAmt>
      <RevenueAmt>3263</RevenueAmt>
      <Desc>PABLOVE SHUTTERBUGS IS A PARTICIPATORY HEALING ARTS EDUCATION PROGRAM THAT TEACHES CHILDREN LIVING WITH CANCER TO DEVELOP THEIR CREATIVE VOICE THROUGH THE ART OF PHOTOGRAPHY. PABLOVE OFFERS A PHOTOGRAPHY CURRICULUM FOR CHILDREN AND TEENS LIVING WITH CANCER THAT INCLUDES AN ALL-COST-PAID INTRODUCTORY CLASS, SUMMER CAMP, AND AN ADVANCED CLASS, WHERE STUDENTS LEARN TO WORK WITH PHOTOGRAPHY AS A MEANS TO ADVOCATE FOR CANCER RESEARCH AND EXPLORE THEIR IDENTITY WHILE LIVING WITH PEDIATRIC CANCER. PABLOVE HAS BEEN ABLE TO GATHER REMARKABLE RESOURCES TO SUPPORT THIS MISSION BY PARTNERING WITH ART INSTITUTIONS SUCH AS THE MUSEUM OF MODERN ART (MOMA) IN NEW YORK CITY, THE HUNTINGTON LIBRARY, ART MUSEUM AND BOTANICAL GARDENS IN LOS ANGELES, AND SAWYER YARDS IN HOUSTON. OUR STUDENTS FIND RESPITE FROM THE DIFFICULT ROUTINE OF TREATMENT WHILE THEY FOCUS ON A FUN NEW ACTIVITY: LEARNING ABOUT PHOTOGRAPHY. EVERY PABLOVE SHUTTERBUGS COURSE CULMINATES IN A GRADUATION AND YEARLY STUDENT GALLERY SHOWS TO CELEBRATE OUR YOUNG PHOTOGRAPHERS - WITH SOME IN-PERSON AND SOME VIRTUAL COURSES IN 2022. PRINT SALES AT PABLOVE'S GALLERY SHOWS DIRECTLY SUPPORT THE POWERED BY PABLOVE RESEARCH GRANTS PROGRAM. 2022 PROGRAM SUCCESSES STAND ON THE SHOULDERS OF THE FOUNDATION'S 2020 PIVOT TO VIRTUAL COURSES. BEYOND THE MAIN PROGRAM CENTERS IN LOS ANGELES, THE BAY AREA, SEATTLE, NEW ENGLAND, NEW YORK, LOUISIANA, AND HOUSTON, PABLOVE IS SERVING KIDS IN 27 STATES NATIONWIDE - INCLUDING A STEADILY GROWING NUMBER OF STUDENTS WHO PARTICIPATE DIRECTLY FROM THEIR HOSPITAL ROOM. FOR THE FIRST TIME SINCE THE PANDEMIC, THE PABLOVE FOUNDATION INVITED SHUTTERBUGS ALUMNI FROM ACROSS THE NATION TO JOIN THE IN-PERSON PABLOVE SHUTTERBUGS SUMMER CAMP IN BEAUTIFUL ARROWHEAD, CA, WHERE MEMORIES AND FRIENDSHIPS WERE MADE TO FIGHT CHILDHOOD CANCER WITH LOVE. IN TOTAL, PABLOVE ENROLLED 215 KIDS IN 13 IN-PERSON AND VIRTUAL CLASSES IN 2022.IT IS EASY TO SEE THE JOY THAT OUR PROGRAMS BRING TO OUR PABLOVE KIDS. MOREOVER, WE ARE COMMITTED TO MAKING A REAL DIFFERENCE IN THE QUALITY OF LIFE (QOL) OF OUR KIDS. WE CONTINUED DATA COLLECTION FOR A COMPREHENSIVE SCIENTIFIC EVALUATION INITIATIVE. BY ADOPTING A WIDELY APPLIED AND VALIDATED QOL ASSESSMENT WE FOUND THAT BY THE END OF THE SHUTTERBUGS PROGRAM, SCORES FOR BOTH THE YOUNGER CHILDREN AND TEENS, SHOWED STATISTICALLY SIGNIFICANT GAINS IN QUALITY OF LIFE. THIS IS A PROFOUNDLY IMPORTANT VALIDATION OF THE POSITIVE EFFECT THAT OUR SHUTTERBUGS ACTIVITIES HAVE FOR THE KIDS WE SERVE, AND PABLOVE WILL CONTINUE TO MONITOR AND EVALUATE THE QOL AND OTHER LEARNING IMPACTS OF OUR COURSES TO CONTINUOUSLY IMPROVE AND OPTIMIZE OUR PROGRAMS TO FURTHER INCREASE BENEFITS.</Desc>
      <ProgSrvcAccomActy2Grp>
        <ExpenseAmt>357391</ExpenseAmt>
        <GrantAmt>112500</GrantAmt>
        <Desc>PABLOVE'S POWERED BY PABLOVE CHILDHOOD CANCER RESEARCH GRANTS PROGRAM IS FOCUSED ON AWARDING $50,000 SEED GRANTS TO PROMISING, EARLY-CAREER INVESTIGATORS, ENABLING THEM TO DISCOVER AND APPLY NOVEL APPROACHES TO UNDERSTANDING CHILDHOOD CANCER, WIDELY DISTRIBUTE THEIR FINDINGS AND GAIN SUBSTANTIALLY GREATER FUNDING FOR LARGER, MORE INTENSE RESEARCH PROJECTS AND PROGRAMS. THIS STRATEGY HAS BEEN REMARKABLY SUCCESSFUL IN PROVIDING A FOUNDATION FOR EXCEPTIONALLY VALUABLE SCIENTIFIC BREAKTHROUGHS IN BOTH SCIENTIFIC AND CLINICAL KNOWLEDGE. PABLOVE'S DREAM IS TO ENSURE THAT NO BRILLIANT, PROMISING SCIENTIST GOES UNFUNDED IN THE INITIAL PHASE OF RESEARCH NEEDED TO ADVANCE FROM BENCH TO BEDSIDE. CHILDREN EVERYWHERE ARE IN NEED AND ARE WAITING FOR THE INNOVATIVE TREATMENT OPTIONS AND CURES THEIR RESEARCH PROVIDES. IN 2022, PABLOVE AWARDED THREE (3) POWERED BY PABLOVE SEED GRANTS, AND CONTINUED SPONSORSHIP OF FOUR (4) ONGOING PROJECTS WITH INVESTIGATORS ACROSS THE GLOBE. PABLOVE'S RESEARCH IS CONDUCTED IN PRESTIGIOUS INSTITUTIONS INCLUDING THE HOSPITAL FOR SICK CHILDREN IN TORONTO, CANADA, THE UNIVERSITY OF TEXAS, SOUTHWEST DALLAS, TEXAS, THE FUNCTIONAL ELECTRICAL STIMULATION INSTITUTE IN CLEVELAND OHIO TO NAME JUST A FEW. EACH PROJECT IS FOCUSED ON A DIFFERENT RARE PEDIATRIC CANCER, INCLUDING OPSOCLONUS MYOCLONUS SYNDROME, PEDIATRIC BRAIN TUMORS, WILMS TUMOR, AND ACUTE MYELOID LEUKEMIA. PABLOVE STRONGLY BELIEVES IN THE NEED TO SUPPORT THESE CUTTING-EDGE INITIATIVES TO REVEAL STUNNING NEW PATHWAYS TOWARD BETTER TREATMENTS AND ULTIMATELY CURES FOR THESE CHALLENGING, OFTEN DEVASTATING, PEDIATRIC CANCERS. PEDIATRIC CANCER RESEARCH CONTINUES TO BE AN UNDERSERVED NEED AND WE ARE HERE TO DO OUR PART TO MAKE A DIFFERENCE. INVESTMENTS TO FIND MORE TREATMENTS AND TO REDUCE SIDE EFFECTS MUST BE FOUND TO PROTECT THE FUTURE OF THESE PRECIOUS KIDS.</Desc>
      </ProgSrvcAccomActy2Grp>
      <TotalProgramServiceExpensesAmt>925284</TotalProgramServiceExpensesAmt>
      <DescribedInSection501c3Ind referenceDocumentId="RetDoc1039100001">1</DescribedInSection501c3Ind>
      <ScheduleBRequiredInd referenceDocumentId="RetDoc1234500001">1</ScheduleBRequiredInd>
      <PoliticalCampaignActyInd>0</PoliticalCampaignActyInd>
      <LobbyingActivitiesInd>0</LobbyingActivitiesInd>
      <SubjectToProxyTaxInd>0</SubjectToProxyTaxInd>
      <DonorAdvisedFundInd referenceDocumentId="RetDoc1040000001">0</DonorAdvisedFundInd>
      <ConservationEasementsInd referenceDocumentId="RetDoc1040000001">0</ConservationEasementsInd>
      <CollectionsOfArtInd referenceDocumentId="RetDoc1040000001">0</CollectionsOfArtInd>
      <CreditCounselingInd referenceDocumentId="RetDoc1040000001">0</CreditCounselingInd>
      <DonorRstrOrQuasiEndowmentsInd>0</DonorRstrOrQuasiEndowmentsInd>
      <ReportLandBuildingEquipmentInd referenceDocumentId="RetDoc1040000001">1</ReportLandBuildingEquipmentInd>
      <ReportInvestmentsOtherSecInd referenceDocumentId="RetDoc1040000001">0</ReportInvestmentsOtherSecInd>
      <ReportProgramRelatedInvstInd referenceDocumentId="RetDoc1040000001">0</ReportProgramRelatedInvstInd>
      <ReportOtherAssetsInd referenceDocumentId="RetDoc1040000001">0</ReportOtherAssetsInd>
      <ReportOtherLiabilitiesInd referenceDocumentId="RetDoc1040000001">1</ReportOtherLiabilitiesInd>
      <IncludeFIN48FootnoteInd referenceDocumentId="RetDoc1040000001">1</IncludeFIN48FootnoteInd>
      <IndependentAuditFinclStmtInd referenceDocumentId="RetDoc1040000001">1</IndependentAuditFinclStmtInd>
      <ConsolidatedAuditFinclStmtInd referenceDocumentId="RetDoc1040000001">0</ConsolidatedAuditFinclStmtInd>
      <SchoolOperatingInd>0</SchoolOperatingInd>
      <ForeignOfficeInd>0</ForeignOfficeInd>
      <ForeignActivitiesInd referenceDocumentId="RetDoc1040500001">1</ForeignActivitiesInd>
      <MoreThan5000KToOrgInd referenceDocumentId="RetDoc1040500001">1</MoreThan5000KToOrgInd>
      <MoreThan5000KToIndividualsInd referenceDocumentId="RetDoc1040500001">0</MoreThan5000KToIndividualsInd>
      <ProfessionalFundraisingInd referenceDocumentId="RetDoc1041300001">0</ProfessionalFundraisingInd>
      <FundraisingActivitiesInd referenceDocumentId="RetDoc1041300001">1</FundraisingActivitiesInd>
      <GamingActivitiesInd referenceDocumentId="RetDoc1041300001">0</GamingActivitiesInd>
      <OperateHospitalInd>0</OperateHospitalInd>
      <GrantsToOrganizationsInd referenceDocumentId="RetDoc1041900001">1</GrantsToOrganizationsInd>
      <GrantsToIndividualsInd referenceDocumentId="RetDoc1041900001">0</GrantsToIndividualsInd>
      <ScheduleJRequiredInd referenceDocumentId="RetDoc1042400001">1</ScheduleJRequiredInd>
      <TaxExemptBondsInd>0</TaxExemptBondsInd>
      <EngagedInExcessBenefitTransInd>0</EngagedInExcessBenefitTransInd>
      <PYExcessBenefitTransInd>0</PYExcessBenefitTransInd>
      <LoanOutstandingInd>0</LoanOutstandingInd>
      <GrantToRelatedPersonInd>0</GrantToRelatedPersonInd>
      <BusinessRlnWithOrgMemInd>0</BusinessRlnWithOrgMemInd>
      <BusinessRlnWithFamMemInd>0</BusinessRlnWithFamMemInd>
      <BusinessRlnWith35CtrlEntInd>0</BusinessRlnWith35CtrlEntInd>
      <DeductibleNonCashContriInd>0</DeductibleNonCashContriInd>
      <DeductibleArtContributionInd>0</DeductibleArtContributionInd>
      <TerminateOperationsInd>0</TerminateOperationsInd>
      <PartialLiquidationInd>0</PartialLiquidationInd>
      <DisregardedEntityInd>0</DisregardedEntityInd>
      <RelatedEntityInd>0</RelatedEntityInd>
      <RelatedOrganizationCtrlEntInd>0</RelatedOrganizationCtrlEntInd>
      <TrnsfrExmptNonChrtblRltdOrgInd>0</TrnsfrExmptNonChrtblRltdOrgInd>
      <ActivitiesConductedPrtshpInd>0</ActivitiesConductedPrtshpInd>
      <ScheduleORequiredInd>1</ScheduleORequiredInd>
      <IRPDocumentCnt>12</IRPDocumentCnt>
      <IRPDocumentW2GCnt>0</IRPDocumentW2GCnt>
      <EmployeeCnt>16</EmployeeCnt>
      <EmploymentTaxReturnsFiledInd>1</EmploymentTaxReturnsFiledInd>
      <UnrelatedBusIncmOverLimitInd>0</UnrelatedBusIncmOverLimitInd>
      <ForeignFinancialAccountInd>0</ForeignFinancialAccountInd>
      <ProhibitedTaxShelterTransInd>0</ProhibitedTaxShelterTransInd>
      <TaxablePartyNotificationInd>0</TaxablePartyNotificationInd>
      <NondeductibleContributionsInd>0</NondeductibleContributionsInd>
      <QuidProQuoContributionsInd>1</QuidProQuoContributionsInd>
      <QuidProQuoContriDisclInd>1</QuidProQuoContriDisclInd>
      <Form8282PropertyDisposedOfInd>0</Form8282PropertyDisposedOfInd>
      <RcvFndsToPayPrsnlBnftCntrctInd>0</RcvFndsToPayPrsnlBnftCntrctInd>
      <PayPremiumsPrsnlBnftCntrctInd>0</PayPremiumsPrsnlBnftCntrctInd>
      <IndoorTanningServicesInd>0</IndoorTanningServicesInd>
      <SubjToTaxRmnrtnExPrchtPymtInd>0</SubjToTaxRmnrtnExPrchtPymtInd>
      <SubjectToExcsTaxNetInvstIncInd>0</SubjectToExcsTaxNetInvstIncInd>
      <InfoInScheduleOPartVIInd>X</InfoInScheduleOPartVIInd>
      <GoverningBodyVotingMembersCnt>13</GoverningBodyVotingMembersCnt>
      <IndependentVotingMemberCnt>12</IndependentVotingMemberCnt>
      <FamilyOrBusinessRlnInd>0</FamilyOrBusinessRlnInd>
      <DelegationOfMgmtDutiesInd>0</DelegationOfMgmtDutiesInd>
      <ChangeToOrgDocumentsInd>0</ChangeToOrgDocumentsInd>
      <MaterialDiversionOrMisuseInd>0</MaterialDiversionOrMisuseInd>
      <MembersOrStockholdersInd>0</MembersOrStockholdersInd>
      <ElectionOfBoardMembersInd>0</ElectionOfBoardMembersInd>
      <DecisionsSubjectToApprovaInd>0</DecisionsSubjectToApprovaInd>
      <MinutesOfGoverningBodyInd>1</MinutesOfGoverningBodyInd>
      <MinutesOfCommitteesInd>1</MinutesOfCommitteesInd>
      <OfficerMailingAddressInd>0</OfficerMailingAddressInd>
      <LocalChaptersInd>0</LocalChaptersInd>
      <Form990ProvidedToGvrnBodyInd>1</Form990ProvidedToGvrnBodyInd>
      <ConflictOfInterestPolicyInd>1</ConflictOfInterestPolicyInd>
      <AnnualDisclosureCoveredPrsnInd>1</AnnualDisclosureCoveredPrsnInd>
      <RegularMonitoringEnfrcInd>1</RegularMonitoringEnfrcInd>
      <WhistleblowerPolicyInd>1</WhistleblowerPolicyInd>
      <DocumentRetentionPolicyInd>1</DocumentRetentionPolicyInd>
      <CompensationProcessCEOInd>1</CompensationProcessCEOInd>
      <CompensationProcessOtherInd>0</CompensationProcessOtherInd>
      <InvestmentInJointVentureInd>0</InvestmentInJointVentureInd>
      <StatesWhereCopyOfReturnIsFldCd>CA</StatesWhereCopyOfReturnIsFldCd>
      <OwnWebsiteInd>X</OwnWebsiteInd>
      <UponRequestInd>X</UponRequestInd>
      <BooksInCareOfDetail>
        <BusinessName>
          <BusinessNameLine1Txt>THE ORGANIZATION</BusinessNameLine1Txt>
        </BusinessName>
        <PhoneNum>3236575557</PhoneNum>
        <USAddress>
          <AddressLine1Txt>3255 CAHUENGA BLVD WEST 210</AddressLine1Txt>
          <CityNm>LOS ANGELES</CityNm>
          <StateAbbreviationCd>CA</StateAbbreviationCd>
          <ZIPCd>90068</ZIPCd>
        </USAddress>
      </BooksInCareOfDetail>
      <Form990PartVIISectionAGrp>
        <PersonNm>TOM KATTUS</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>COURTNEY HORVATH PHD</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>KATHERINE QUICK ROSA</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>KOMAL SHETH</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>CHARLOTTE ROLFS</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>PAUL ADAMS</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>TINA SCHWARTZ</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>BLAIR HERTER</PersonNm>
        <TitleTxt>CHAIRMAN OF THE BOARD</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>KERSTIN LYNAM</PersonNm>
        <TitleTxt>CEO</TitleTxt>
        <AverageHoursPerWeekRt>50.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>165000</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>2070</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>JEFFREY S DOME MD PHD</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <TotalReportableCompFromOrgAmt>165000</TotalReportableCompFromOrgAmt>
      <TotReportableCompRltdOrgAmt>0</TotReportableCompRltdOrgAmt>
      <TotalOtherCompensationAmt>2070</TotalOtherCompensationAmt>
      <IndivRcvdGreaterThan100KCnt>1</IndivRcvdGreaterThan100KCnt>
      <FormerOfcrEmployeesListedInd>0</FormerOfcrEmployeesListedInd>
      <TotalCompGreaterThan150KInd>1</TotalCompGreaterThan150KInd>
      <CompensationFromOtherSrcsInd>0</CompensationFromOtherSrcsInd>
      <CntrctRcvdGreaterThan100KCnt>0</CntrctRcvdGreaterThan100KCnt>
      <FundraisingAmt>-26606</FundraisingAmt>
      <GovernmentGrantsAmt>69098</GovernmentGrantsAmt>
      <AllOtherContributionsAmt>663709</AllOtherContributionsAmt>
      <NoncashContributionsAmt>946</NoncashContributionsAmt>
      <TotalContributionsAmt>706201</TotalContributionsAmt>
      <InvestmentIncomeGrp>
        <TotalRevenueColumnAmt>34170</TotalRevenueColumnAmt>
        <ExclusionAmt>34170</ExclusionAmt>
      </InvestmentIncomeGrp>
      <GrossAmountSalesAssetsGrp>
        <SecuritiesAmt>589728</SecuritiesAmt>
      </GrossAmountSalesAssetsGrp>
      <LessCostOthBasisSalesExpnssGrp>
        <SecuritiesAmt>589157</SecuritiesAmt>
      </LessCostOthBasisSalesExpnssGrp>
      <GainOrLossGrp>
        <SecuritiesAmt>571</SecuritiesAmt>
      </GainOrLossGrp>
      <NetGainOrLossInvestmentsGrp>
        <TotalRevenueColumnAmt>571</TotalRevenueColumnAmt>
        <ExclusionAmt>571</ExclusionAmt>
      </NetGainOrLossInvestmentsGrp>
      <FundraisingGrossIncomeAmt>292259</FundraisingGrossIncomeAmt>
      <ContriRptFundraisingEventAmt>-26606</ContriRptFundraisingEventAmt>
      <FundraisingDirectExpensesAmt>292259</FundraisingDirectExpensesAmt>
      <NetIncmFromFundraisingEvtGrp>
        <TotalRevenueColumnAmt>0</TotalRevenueColumnAmt>
      </NetIncmFromFundraisingEvtGrp>
      <GrossSalesOfInventoryAmt>3263</GrossSalesOfInventoryAmt>
      <CostOfGoodsSoldAmt>0</CostOfGoodsSoldAmt>
      <NetIncomeOrLossGrp>
        <TotalRevenueColumnAmt>3263</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>3263</RelatedOrExemptFuncIncomeAmt>
      </NetIncomeOrLossGrp>
      <OtherRevenueMiscGrp>
        <Desc>OTHER INCOME</Desc>
        <BusinessCd>900099</BusinessCd>
        <TotalRevenueColumnAmt>31</TotalRevenueColumnAmt>
        <ExclusionAmt>31</ExclusionAmt>
      </OtherRevenueMiscGrp>
      <OtherRevenueTotalAmt>31</OtherRevenueTotalAmt>
      <TotalRevenueGrp>
        <TotalRevenueColumnAmt>744236</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>3263</RelatedOrExemptFuncIncomeAmt>
        <UnrelatedBusinessRevenueAmt>0</UnrelatedBusinessRevenueAmt>
        <ExclusionAmt>34772</ExclusionAmt>
      </TotalRevenueGrp>
      <InfoInScheduleOPartIXInd>X</InfoInScheduleOPartIXInd>
      <GrantsToDomesticOrgsGrp>
        <TotalAmt>60000</TotalAmt>
        <ProgramServicesAmt>60000</ProgramServicesAmt>
      </GrantsToDomesticOrgsGrp>
      <ForeignGrantsGrp>
        <TotalAmt>52500</TotalAmt>
        <ProgramServicesAmt>52500</ProgramServicesAmt>
      </ForeignGrantsGrp>
      <CompCurrentOfcrDirectorsGrp>
        <TotalAmt>167071</TotalAmt>
        <ProgramServicesAmt>120290</ProgramServicesAmt>
        <ManagementAndGeneralAmt>5013</ManagementAndGeneralAmt>
        <FundraisingAmt>41768</FundraisingAmt>
      </CompCurrentOfcrDirectorsGrp>
      <OtherSalariesAndWagesGrp>
        <TotalAmt>575018</TotalAmt>
        <ProgramServicesAmt>414012</ProgramServicesAmt>
        <ManagementAndGeneralAmt>17251</ManagementAndGeneralAmt>
        <FundraisingAmt>143755</FundraisingAmt>
      </OtherSalariesAndWagesGrp>
      <PensionPlanContributionsGrp>
        <TotalAmt>2024</TotalAmt>
        <ProgramServicesAmt>1458</ProgramServicesAmt>
        <ManagementAndGeneralAmt>60</ManagementAndGeneralAmt>
        <FundraisingAmt>506</FundraisingAmt>
      </PensionPlanContributionsGrp>
      <OtherEmployeeBenefitsGrp>
        <TotalAmt>38989</TotalAmt>
        <ProgramServicesAmt>28072</ProgramServicesAmt>
        <ManagementAndGeneralAmt>1170</ManagementAndGeneralAmt>
        <FundraisingAmt>9747</FundraisingAmt>
      </OtherEmployeeBenefitsGrp>
      <PayrollTaxesGrp>
        <TotalAmt>60796</TotalAmt>
        <ProgramServicesAmt>43773</ProgramServicesAmt>
        <ManagementAndGeneralAmt>1824</ManagementAndGeneralAmt>
        <FundraisingAmt>15199</FundraisingAmt>
      </PayrollTaxesGrp>
      <FeesForServicesAccountingGrp>
        <TotalAmt>77092</TotalAmt>
        <ManagementAndGeneralAmt>77092</ManagementAndGeneralAmt>
      </FeesForServicesAccountingGrp>
      <FeesForSrvcInvstMgmntFeesGrp>
        <TotalAmt>11228</TotalAmt>
        <ManagementAndGeneralAmt>11228</ManagementAndGeneralAmt>
      </FeesForSrvcInvstMgmntFeesGrp>
      <FeesForServicesOtherGrp>
        <TotalAmt>185176</TotalAmt>
        <ProgramServicesAmt>39865</ProgramServicesAmt>
        <ManagementAndGeneralAmt>140875</ManagementAndGeneralAmt>
        <FundraisingAmt>4436</FundraisingAmt>
      </FeesForServicesOtherGrp>
      <AdvertisingGrp>
        <TotalAmt>11000</TotalAmt>
        <ProgramServicesAmt>7920</ProgramServicesAmt>
        <ManagementAndGeneralAmt>330</ManagementAndGeneralAmt>
        <FundraisingAmt>2750</FundraisingAmt>
      </AdvertisingGrp>
      <OfficeExpensesGrp>
        <TotalAmt>49651</TotalAmt>
        <ProgramServicesAmt>20662</ProgramServicesAmt>
        <ManagementAndGeneralAmt>11794</ManagementAndGeneralAmt>
        <FundraisingAmt>17195</FundraisingAmt>
      </OfficeExpensesGrp>
      <InformationTechnologyGrp>
        <TotalAmt>10795</TotalAmt>
        <ProgramServicesAmt>7772</ProgramServicesAmt>
        <ManagementAndGeneralAmt>324</ManagementAndGeneralAmt>
        <FundraisingAmt>2699</FundraisingAmt>
      </InformationTechnologyGrp>
      <OccupancyGrp>
        <TotalAmt>56558</TotalAmt>
        <ProgramServicesAmt>39107</ProgramServicesAmt>
        <ManagementAndGeneralAmt>5259</ManagementAndGeneralAmt>
        <FundraisingAmt>12192</FundraisingAmt>
      </OccupancyGrp>
      <TravelGrp>
        <TotalAmt>37931</TotalAmt>
        <ProgramServicesAmt>27309</ProgramServicesAmt>
        <ManagementAndGeneralAmt>5975</ManagementAndGeneralAmt>
        <FundraisingAmt>4647</FundraisingAmt>
      </TravelGrp>
      <DepreciationDepletionGrp>
        <TotalAmt>1555</TotalAmt>
        <ManagementAndGeneralAmt>1555</ManagementAndGeneralAmt>
      </DepreciationDepletionGrp>
      <InsuranceGrp>
        <TotalAmt>24462</TotalAmt>
        <ProgramServicesAmt>17612</ProgramServicesAmt>
        <ManagementAndGeneralAmt>734</ManagementAndGeneralAmt>
        <FundraisingAmt>6116</FundraisingAmt>
      </InsuranceGrp>
      <OtherExpensesGrp>
        <Desc>DUES AND SUBSCRIPTIONS</Desc>
        <TotalAmt>55044</TotalAmt>
        <ProgramServicesAmt>10371</ProgramServicesAmt>
        <ManagementAndGeneralAmt>37906</ManagementAndGeneralAmt>
        <FundraisingAmt>6767</FundraisingAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>SUPPLIES AND EQUIPMENT</Desc>
        <TotalAmt>39076</TotalAmt>
        <ProgramServicesAmt>34561</ProgramServicesAmt>
        <ManagementAndGeneralAmt>3706</ManagementAndGeneralAmt>
        <FundraisingAmt>809</FundraisingAmt>
      </OtherExpensesGrp>
      <TotalFunctionalExpensesGrp>
        <TotalAmt>1515966</TotalAmt>
        <ProgramServicesAmt>925284</ProgramServicesAmt>
        <ManagementAndGeneralAmt>322096</ManagementAndGeneralAmt>
        <FundraisingAmt>268586</FundraisingAmt>
      </TotalFunctionalExpensesGrp>
      <CashNonInterestBearingGrp>
        <BOYAmt>757445</BOYAmt>
        <EOYAmt>332049</EOYAmt>
      </CashNonInterestBearingGrp>
      <SavingsAndTempCashInvstGrp>
        <BOYAmt>54938</BOYAmt>
        <EOYAmt>12614</EOYAmt>
      </SavingsAndTempCashInvstGrp>
      <PledgesAndGrantsReceivableGrp>
        <BOYAmt>182712</BOYAmt>
        <EOYAmt>114989</EOYAmt>
      </PledgesAndGrantsReceivableGrp>
      <PrepaidExpensesDefrdChargesGrp>
        <BOYAmt>4039</BOYAmt>
      </PrepaidExpensesDefrdChargesGrp>
      <LandBldgEquipCostOrOtherBssAmt>83693</LandBldgEquipCostOrOtherBssAmt>
      <LandBldgEquipAccumDeprecAmt>68466</LandBldgEquipAccumDeprecAmt>
      <LandBldgEquipBasisNetGrp>
        <BOYAmt>7450</BOYAmt>
        <EOYAmt>15227</EOYAmt>
      </LandBldgEquipBasisNetGrp>
      <InvestmentsPubTradedSecGrp>
        <BOYAmt>1819677</BOYAmt>
        <EOYAmt>1310883</EOYAmt>
      </InvestmentsPubTradedSecGrp>
      <OtherAssetsTotalGrp>
        <BOYAmt>12505</BOYAmt>
        <EOYAmt>92221</EOYAmt>
      </OtherAssetsTotalGrp>
      <TotalAssetsGrp>
        <BOYAmt>2838766</BOYAmt>
        <EOYAmt>1877983</EOYAmt>
      </TotalAssetsGrp>
      <AccountsPayableAccrExpnssGrp>
        <BOYAmt>78027</BOYAmt>
        <EOYAmt>54760</EOYAmt>
      </AccountsPayableAccrExpnssGrp>
      <OtherLiabilitiesGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>90163</EOYAmt>
      </OtherLiabilitiesGrp>
      <TotalLiabilitiesGrp>
        <BOYAmt>78027</BOYAmt>
        <EOYAmt>144923</EOYAmt>
      </TotalLiabilitiesGrp>
      <OrganizationFollowsFASB117Ind>X</OrganizationFollowsFASB117Ind>
      <NoDonorRestrictionNetAssetsGrp>
        <BOYAmt>2445494</BOYAmt>
        <EOYAmt>1425244</EOYAmt>
      </NoDonorRestrictionNetAssetsGrp>
      <DonorRestrictionNetAssetsGrp>
        <BOYAmt>315245</BOYAmt>
        <EOYAmt>307816</EOYAmt>
      </DonorRestrictionNetAssetsGrp>
      <TotalNetAssetsFundBalanceGrp>
        <BOYAmt>2760739</BOYAmt>
        <EOYAmt>1733060</EOYAmt>
      </TotalNetAssetsFundBalanceGrp>
      <TotLiabNetAssetsFundBalanceGrp>
        <BOYAmt>2838766</BOYAmt>
        <EOYAmt>1877983</EOYAmt>
      </TotLiabNetAssetsFundBalanceGrp>
      <ReconcilationRevenueExpnssAmt>-771730</ReconcilationRevenueExpnssAmt>
      <NetUnrlzdGainsLossesInvstAmt>-255949</NetUnrlzdGainsLossesInvstAmt>
      <OtherChangesInNetAssetsAmt>0</OtherChangesInNetAssetsAmt>
      <InfoInScheduleOPartXIIInd>X</InfoInScheduleOPartXIIInd>
      <MethodOfAccountingAccrualInd>X</MethodOfAccountingAccrualInd>
      <AccountantCompileOrReviewInd>0</AccountantCompileOrReviewInd>
      <FSAuditedInd>1</FSAuditedInd>
      <FSAuditedBasisGrp>
        <SeparateBasisFinclStmtInd>X</SeparateBasisFinclStmtInd>
      </FSAuditedBasisGrp>
      <AuditCommitteeInd>1</AuditCommitteeInd>
      <FederalGrantAuditRequiredInd>0</FederalGrantAuditRequiredInd>
    </IRS990>
    <IRS990ScheduleA documentId="RetDoc1039100001">
      <PublicOrganization170Ind>X</PublicOrganization170Ind>
      <GiftsGrantsContriRcvd170Grp>
        <CurrentTaxYearMinus4YearsAmt>2301159</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>1394951</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>1035385</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>1565271</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>706201</CurrentTaxYearAmt>
        <TotalAmt>7002967</TotalAmt>
      </GiftsGrantsContriRcvd170Grp>
      <TotalCalendarYear170Grp>
        <CurrentTaxYearMinus4YearsAmt>2301159</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>1394951</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>1035385</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>1565271</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>706201</CurrentTaxYearAmt>
        <TotalAmt>7002967</TotalAmt>
      </TotalCalendarYear170Grp>
      <SubstantialContributorsTotAmt>1304079</SubstantialContributorsTotAmt>
      <PublicSupportTotal170Amt>5698888</PublicSupportTotal170Amt>
      <GrossInvestmentIncome170Grp>
        <CurrentTaxYearMinus4YearsAmt>104764</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>70968</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>40829</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>42307</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>34170</CurrentTaxYearAmt>
        <TotalAmt>293038</TotalAmt>
      </GrossInvestmentIncome170Grp>
      <OtherIncome170Grp>
        <CurrentTaxYearAmt>31</CurrentTaxYearAmt>
        <TotalAmt>31</TotalAmt>
      </OtherIncome170Grp>
      <TotalSupportAmt>7296036</TotalSupportAmt>
      <GrossReceiptsRltdActivitiesAmt>106358</GrossReceiptsRltdActivitiesAmt>
      <PublicSupportCY170Pct>0.78110</PublicSupportCY170Pct>
      <PublicSupportPY170Pct>0.77100</PublicSupportPY170Pct>
      <ThirtyThrPctSuprtTestsCY170Ind>X</ThirtyThrPctSuprtTestsCY170Ind>
      <Form990ScheduleAPartVIGrp>
        <FormAndLineReferenceDesc>SCHEDULE A, PART VI, LIST OF UNUSUAL GRANTS:</FormAndLineReferenceDesc>
        <ExplanationTxt>DESCRIPTION: AMOUNT: 0.</ExplanationTxt>
      </Form990ScheduleAPartVIGrp>
    </IRS990ScheduleA>
    <IRS990ScheduleB documentId="RetDoc1234500001">
      <ContributorInformationGrp>
        <ContributorNum>RESTRICTED</ContributorNum>
        <ContributorBusinessName>
          <BusinessNameLine1>RESTRICTED</BusinessNameLine1>
        </ContributorBusinessName>
        <ContributorUSAddress>
          <AddressLine1>RESTRICTED</AddressLine1>
          <AddressLine2>RESTRICTED</AddressLine2>
          <City>RESTRICTED</City>
          <State>RESTRICTED</State>
          <ZIPCode>RESTRICTED</ZIPCode>
        </ContributorUSAddress>
        <TotalContributionsAmt>RESTRICTED</TotalContributionsAmt>
      </ContributorInformationGrp>
    </IRS990ScheduleB>
    <IRS990ScheduleD documentId="RetDoc1040000001">
      <LeaseholdImprovementsGrp>
        <OtherCostOrOtherBasisAmt>9974</OtherCostOrOtherBasisAmt>
        <DepreciationAmt>9974</DepreciationAmt>
        <BookValueAmt>0</BookValueAmt>
      </LeaseholdImprovementsGrp>
      <EquipmentGrp>
        <OtherCostOrOtherBasisAmt>35005</OtherCostOrOtherBasisAmt>
        <DepreciationAmt>27228</DepreciationAmt>
        <BookValueAmt>7777</BookValueAmt>
      </EquipmentGrp>
      <OtherLandBuildingsGrp>
        <OtherCostOrOtherBasisAmt>38714</OtherCostOrOtherBasisAmt>
        <DepreciationAmt>31264</DepreciationAmt>
        <BookValueAmt>7450</BookValueAmt>
      </OtherLandBuildingsGrp>
      <TotalBookValueLandBuildingsAmt>15227</TotalBookValueLandBuildingsAmt>
      <OtherLiabilitiesOrgGrp>
        <Desc>OPERATING LEASE LIABILITY</Desc>
        <Amt>90163</Amt>
      </OtherLiabilitiesOrgGrp>
      <TotalLiabilityAmt>90163</TotalLiabilityAmt>
      <FootnoteTextInd>X</FootnoteTextInd>
      <TotalRevEtcAuditedFinclStmtAmt>487809</TotalRevEtcAuditedFinclStmtAmt>
      <NetUnrealizedGainsInvstAmt>-255949</NetUnrealizedGainsInvstAmt>
      <DonatedServicesAndUseFcltsAmt>10750</DonatedServicesAndUseFcltsAmt>
      <RevenueNotReportedAmt>-245199</RevenueNotReportedAmt>
      <RevenueSubtotalAmt>733008</RevenueSubtotalAmt>
      <InvestmentExpensesNotIncldAmt>11228</InvestmentExpensesNotIncldAmt>
      <RevenueNotReportedFinclStmtAmt>11228</RevenueNotReportedFinclStmtAmt>
      <TotalRevenuePerForm990Amt>744236</TotalRevenuePerForm990Amt>
      <TotExpnsEtcAuditedFinclStmtAmt>1515488</TotExpnsEtcAuditedFinclStmtAmt>
      <DonatedServicesUseFcltsAmt>10750</DonatedServicesUseFcltsAmt>
      <ExpensesNotReportedAmt>10750</ExpensesNotReportedAmt>
      <ExpensesSubtotalAmt>1504738</ExpensesSubtotalAmt>
      <InvestmentExpensesNotIncld2Amt>11228</InvestmentExpensesNotIncld2Amt>
      <ExpensesNotRptFinclStmtAmt>11228</ExpensesNotRptFinclStmtAmt>
      <TotalExpensesPerForm990Amt>1515966</TotalExpensesPerForm990Amt>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART X, LINE 2:</FormAndLineReferenceDesc>
        <ExplanationTxt>ACCOUNTING STANDARDS REQUIRE AN ORGANIZATION TO EVALUATE ITS TAX POSITIONS AND PROVIDE FOR A LIABILITY FOR ANY POSITIONS THAT WOULD NOT BE CONSIDERED 'MORE LIKELY THAN NOT' TO BE UPHELD UNDER A TAX AUTHORITY EXAMINATION. MANAGEMENT HAS EVALUATED ITS TAX POSITIONS AND HAS CONCLUDED THAT A PROVISION FOR A TAX LIABILITY IS NOT NECESSARY AT DECEMBER 31, 2022. GENERALLY, PABLOVE'S INFORMATION RETURNS REMAIN OPEN FOR EXAMINATION FOR A PERIOD OF THREE (FEDERAL) OR FOUR (STATE OF CALIFORNIA) YEARS FROM THE DATE OF FILING.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleD>
    <IRS990ScheduleF documentId="RetDoc1040500001">
      <GrantRecordsMaintainedInd>0</GrantRecordsMaintainedInd>
      <AccountActivitiesOutsideUSGrp>
        <RegionTxt>EUROPE (INCLUDING ICELAND &amp; GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM</RegionTxt>
        <OfficesCnt>0</OfficesCnt>
        <EmployeeCnt>0</EmployeeCnt>
        <TypeOfActivitiesConductedTxt>RESEARCH GRANTS TO RECIPIENTS LOCATED IN REGION</TypeOfActivitiesConductedTxt>
        <SpecificServicesProvidedTxt>RECIPIENT PERFORMS PEDIATRIC CANCER RESEARCH</SpecificServicesProvidedTxt>
        <RegionTotalExpendituresAmt>52500</RegionTotalExpendituresAmt>
      </AccountActivitiesOutsideUSGrp>
      <SubtotalOfficesCnt>0</SubtotalOfficesCnt>
      <SubtotalEmployeesCnt>0</SubtotalEmployeesCnt>
      <ContinuationTotalOfficeCnt>0</ContinuationTotalOfficeCnt>
      <ContinuationTotalEmployeeCnt>0</ContinuationTotalEmployeeCnt>
      <TotalOfficeCnt>0</TotalOfficeCnt>
      <TotalEmployeeCnt>0</TotalEmployeeCnt>
      <SubtotalSpentAmt>52500</SubtotalSpentAmt>
      <ContinuationSpentAmt>0</ContinuationSpentAmt>
      <TotalSpentAmt>52500</TotalSpentAmt>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>EUROPE (INCLUDING ICELAND &amp; GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM</RegionTxt>
        <PurposeOfGrantTxt>CHILDHOOD CANCER RESEARCH</PurposeOfGrantTxt>
        <CashGrantAmt>30000</CashGrantAmt>
        <MannerOfCashDisbursementTxt>BANK WIRE</MannerOfCashDisbursementTxt>
        <NonCashAssistanceAmt>0</NonCashAssistanceAmt>
        <ValuationMethodUsedDesc>FMV</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>EUROPE (INCLUDING ICELAND &amp; GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM</RegionTxt>
        <PurposeOfGrantTxt>CHILDHOOD CANCER RESEARCH</PurposeOfGrantTxt>
        <CashGrantAmt>22500</CashGrantAmt>
        <MannerOfCashDisbursementTxt>BANK WIRE</MannerOfCashDisbursementTxt>
        <NonCashAssistanceAmt>0</NonCashAssistanceAmt>
        <ValuationMethodUsedDesc>FMV</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <Total501c3OrgCnt>2</Total501c3OrgCnt>
      <TransferToForeignCorpInd>0</TransferToForeignCorpInd>
      <InterestInForeignTrustInd>0</InterestInForeignTrustInd>
      <ForeignCorpOwnershipInd>0</ForeignCorpOwnershipInd>
      <PassiveForeignInvestmestCoInd>0</PassiveForeignInvestmestCoInd>
      <ForeignPartnershipInd>0</ForeignPartnershipInd>
      <BoycottCountriesInd>0</BoycottCountriesInd>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART I, LINE 2:</FormAndLineReferenceDesc>
        <ExplanationTxt>DIRECT OVERSIGHT THROUGH WRITTEN PROGRESS/WORK REPORTS FROM GRANTEE.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART III ACCOUNTING METHOD:</FormAndLineReferenceDesc>
      </SupplementalInformationDetail>
    </IRS990ScheduleF>
    <IRS990ScheduleG documentId="RetDoc1041300001">
      <FundraisingEventInformationGrp>
        <Event1Nm>PABLOVE ACROSS AMERICA</Event1Nm>
        <GrossReceiptsEvent1Amt>265653</GrossReceiptsEvent1Amt>
        <CharitableContriEvent1Amt>-26606</CharitableContriEvent1Amt>
        <GrossRevenueEvent1Amt>292259</GrossRevenueEvent1Amt>
        <NonCashPrizesEvent1Amt>363</NonCashPrizesEvent1Amt>
        <RentFacilityCostsEvent1Amt>4459</RentFacilityCostsEvent1Amt>
        <FoodAndBeverageEvent1Amt>3622</FoodAndBeverageEvent1Amt>
        <EntertainmentEvent1Amt>150606</EntertainmentEvent1Amt>
        <OtherDirectExpensesEvent1Amt>133209</OtherDirectExpensesEvent1Amt>
        <GrossReceiptsTotalAmt>265653</GrossReceiptsTotalAmt>
        <CharitableContributionsTotAmt>-26606</CharitableContributionsTotAmt>
        <GrossRevenueTotalEventsAmt>292259</GrossRevenueTotalEventsAmt>
        <NonCashPrizesTotalEventsAmt>363</NonCashPrizesTotalEventsAmt>
        <RentFcltyCostsTotalEventsAmt>4459</RentFcltyCostsTotalEventsAmt>
        <FoodAndBeverageTotalEventsAmt>3622</FoodAndBeverageTotalEventsAmt>
        <EntertainmentTotalEventsAmt>150606</EntertainmentTotalEventsAmt>
        <OthDirectExpnssTotalEventsAmt>133209</OthDirectExpnssTotalEventsAmt>
        <DirectExpenseSummaryEventsAmt>292259</DirectExpenseSummaryEventsAmt>
        <NetIncomeSummaryAmt>0</NetIncomeSummaryAmt>
      </FundraisingEventInformationGrp>
    </IRS990ScheduleG>
    <IRS990ScheduleI documentId="RetDoc1041900001">
      <GrantRecordsMaintainedInd>1</GrantRecordsMaintainedInd>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>BAYLOR COLLEGE OF MEDICINE</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>1 BAYLOR PLAZA</AddressLine1Txt>
          <CityNm>HOUSTON</CityNm>
          <StateAbbreviationCd>TX</StateAbbreviationCd>
          <ZIPCd>77030</ZIPCd>
        </USAddress>
        <RecipientEIN>741613878</RecipientEIN>
        <IRCSectionDesc>501(C)(3)</IRCSectionDesc>
        <CashGrantAmt>7500</CashGrantAmt>
        <NonCashAssistanceAmt>0</NonCashAssistanceAmt>
        <PurposeOfGrantTxt>CHILDHOOD CANCER RESEARCH</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>CHILDREN'S HOSPITAL MEDICAL CENTER</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>4650 SUNSET BLVD</AddressLine1Txt>
          <CityNm>LOS ANGELES</CityNm>
          <StateAbbreviationCd>CA</StateAbbreviationCd>
          <ZIPCd>90027</ZIPCd>
        </USAddress>
        <RecipientEIN>521640403</RecipientEIN>
        <IRCSectionDesc>501(C)(3)</IRCSectionDesc>
        <CashGrantAmt>22500</CashGrantAmt>
        <NonCashAssistanceAmt>0</NonCashAssistanceAmt>
        <PurposeOfGrantTxt>CHILDHOOD CANCER RESEARCH</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>BOARD OF REGENTS OF THE UNIVERSITY OF WISCONSIN SYSTEM</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>3333 BURNET AVENUE</AddressLine1Txt>
          <CityNm>CINCINNATI</CityNm>
          <StateAbbreviationCd>OH</StateAbbreviationCd>
          <ZIPCd>45229</ZIPCd>
        </USAddress>
        <RecipientEIN>371625460</RecipientEIN>
        <CashGrantAmt>30000</CashGrantAmt>
        <NonCashAssistanceAmt>0</NonCashAssistanceAmt>
        <PurposeOfGrantTxt>CHILDHOOD CANCER RESEARCH</PurposeOfGrantTxt>
      </RecipientTable>
      <Total501c3OrgCnt>2</Total501c3OrgCnt>
      <TotalOtherOrgCnt>1</TotalOtherOrgCnt>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>SCHEDULE I, PART I, LINE 2</FormAndLineReferenceDesc>
        <ExplanationTxt>ALL GRANT RECIPIENTS SUBMIT AN AWARD BUDGET THAT IS REVIEWED BY THE SCIENTIFIC ADVISORY COMMITTEE AND APPROVED BY THE BOARD OF DIRECTORS. A MID-TERM BUDGET UPDATE SHOWING EXPENSES AND FUNDS USED TO DATE IS REQUIRED. A FINAL BUDGET REPORT SHOWING FUNDS USED AND ANY FUNDS REMAINING IS ALSO REQUIRED.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleI>
    <IRS990ScheduleJ documentId="RetDoc1042400001">
      <BoardOrCommitteeApprovalInd>X</BoardOrCommitteeApprovalInd>
      <SeverancePaymentInd>0</SeverancePaymentInd>
      <SupplementalNonqualRtrPlanInd>0</SupplementalNonqualRtrPlanInd>
      <EquityBasedCompArrngmInd>0</EquityBasedCompArrngmInd>
      <CompBasedOnRevenueOfFlngOrgInd>0</CompBasedOnRevenueOfFlngOrgInd>
      <CompBsdOnRevRelatedOrgsInd>0</CompBsdOnRevRelatedOrgsInd>
      <CompBsdNetEarnsFlngOrgInd>0</CompBsdNetEarnsFlngOrgInd>
      <CompBsdNetEarnsRltdOrgsInd>0</CompBsdNetEarnsRltdOrgsInd>
      <AnyNonFixedPaymentsInd>0</AnyNonFixedPaymentsInd>
      <InitialContractExceptionInd>0</InitialContractExceptionInd>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>KERSTIN LYNAM</PersonNm>
        <TitleTxt>CEO</TitleTxt>
        <BaseCompensationFilingOrgAmt>165000</BaseCompensationFilingOrgAmt>
        <CompensationBasedOnRltdOrgsAmt>0</CompensationBasedOnRltdOrgsAmt>
        <BonusFilingOrganizationAmount>0</BonusFilingOrganizationAmount>
        <BonusRelatedOrganizationsAmt>0</BonusRelatedOrganizationsAmt>
        <OtherCompensationFilingOrgAmt>0</OtherCompensationFilingOrgAmt>
        <OtherCompensationRltdOrgsAmt>0</OtherCompensationRltdOrgsAmt>
        <DeferredCompensationFlngOrgAmt>1650</DeferredCompensationFlngOrgAmt>
        <DeferredCompRltdOrgsAmt>0</DeferredCompRltdOrgsAmt>
        <NontaxableBenefitsFilingOrgAmt>420</NontaxableBenefitsFilingOrgAmt>
        <NontaxableBenefitsRltdOrgsAmt>0</NontaxableBenefitsRltdOrgsAmt>
        <TotalCompensationFilingOrgAmt>167070</TotalCompensationFilingOrgAmt>
        <TotalCompensationRltdOrgsAmt>0</TotalCompensationRltdOrgsAmt>
        <CompReportPrior990FilingOrgAmt>0</CompReportPrior990FilingOrgAmt>
        <CompReportPrior990RltdOrgsAmt>0</CompReportPrior990RltdOrgsAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
    </IRS990ScheduleJ>
    <IRS990ScheduleO documentId="RetDoc1044400001">
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION B, LINE 11B</FormAndLineReferenceDesc>
        <ExplanationTxt>THE INFORMATION RETURN IS SENT TO THE FINANCE COMMITTEE FOR REVIEW AND APPROVAL. THE FULL BOARD OF DIRECTORS REVIEWS THE INFORMATION RETURN.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION B, LINE 12C</FormAndLineReferenceDesc>
        <ExplanationTxt>BOARD MEMBERS AND KEY EMPLOYEES ARE REQUIRED ANNUALLY TO REVIEW AND SIGN A CONFLICT OF INTEREST DISCLOSURE STATEMENT. THE ORGANIZATION'S CONFLICT OF INTEREST POLICY REQUIRES THAT A MEMBER WITH A FINANCIAL INTEREST, DIRECTLY OR INDIRECTLY, THROUGH BUSINESS, INVESTMENT OR FAMILY MEMBER, BE EXCLUDED FROM ANY DETERMINATION ON ANY TRANSACTION OR ARRANGEMENT THAT MAY BE ENTERED BY ORGANIZATION AFFECTING SUCH AN INTERESTED PERSON.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION B, LINE 15A</FormAndLineReferenceDesc>
        <ExplanationTxt>THE ORGANIZATION'S BOARD VOTES ONLY ON THE EXECUTIVE DIRECTOR'S SALARY.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION C, LINE 18</FormAndLineReferenceDesc>
        <ExplanationTxt>THE ORGANIZATION'S FORM 990 IS AVAILABLE FOR PUBLIC INSPECTION ON ITS WEBSITE.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION C, LINE 19</FormAndLineReferenceDesc>
        <ExplanationTxt>THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE UPON REQUEST.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART IX, LINE 11G</FormAndLineReferenceDesc>
        <ExplanationTxt>OTHER PROFESSIONAL FEES &amp; EXPENSES: PROGRAM SERVICE EXPENSES 39,865. MANAGEMENT AND GENERAL EXPENSES 140,875. FUNDRAISING EXPENSES 4,436. TOTAL EXPENSES 185,176.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART XII, LINE 2C</FormAndLineReferenceDesc>
        <ExplanationTxt>PABLOVE'S FINANCE COMMITTEE HAS RESPONSIBILITY FOR THE OVERSIGHT OF THE AUDIT OF ITS FINANCIAL STATEMENTS AND SELECTION OF THE INDEPENDENT AUDITOR, SUBJECT TO APPROVAL OF THE BOARD OF DIRECTORS. THIS RESPONSIBILITY IS UNCHANGED FROM THE PRIOR YEAR.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleO>
  </ReturnData>
</Return>
